2009
DOI: 10.1159/000222777
|View full text |Cite
|
Sign up to set email alerts
|

Coping Strategy and Anxiety Evolution in Multiple Sclerosis Patients Initiating Interferon-Beta Treatment

Abstract: This study (ACSEPT) aimed to assess anxiety evolution according to coping strategy in patients with multiple sclerosis (MS) during their first months of treatment with interferon (IFN)-β1a. Recently diagnosed relapsing-remitting MS (RRMS) patients (n = 255) were included and received standardized information on MS. At inclusion, the preferred coping mode was determined using the Coping Inventory for Stressful Situations (CISS). Anxiety and depression were assessed at inclusion and after 3 months using the Spie… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

4
13
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 20 publications
(17 citation statements)
references
References 60 publications
(32 reference statements)
4
13
0
Order By: Relevance
“…However, the relationship between high levels of depression and the use of an emotion-oriented strategy is consistent with published data [10,31] . The impact of fatigue measured by the FIS-MS was comparable with the findings of previous studies [35][36][37] .…”
Section: Coping In Ms Patients Starting Fingolimodsupporting
confidence: 90%
See 2 more Smart Citations
“…However, the relationship between high levels of depression and the use of an emotion-oriented strategy is consistent with published data [10,31] . The impact of fatigue measured by the FIS-MS was comparable with the findings of previous studies [35][36][37] .…”
Section: Coping In Ms Patients Starting Fingolimodsupporting
confidence: 90%
“…Other studies of coping in MS which used the CISS [10,29,30] , or more frequently the COPE questionnaire [23, [31][32][33]] , have revealed a high level of recourse to non-adaptive coping strategies and an association between non-adaptive coping and anxiety or depression [34] . However, it is difficult to compare the results obtained with different questionnaires due to different content structure or different definitions of coping strategies.…”
Section: Coping In Ms Patients Starting Fingolimodmentioning
confidence: 99%
See 1 more Smart Citation
“…Psychological coping has proved to be crucially important for adjusting to the adaptive demands of chronic diseases, and in the last few years it has received growing interest in MS [12,13]. However, few studies tried to identify coping strategies during therapy initiation which may allow customized support and improve treatment adherence [14].…”
Section: Introductionmentioning
confidence: 99%
“…The rate of depression in MS is higher than that in most other chronic or neurologic diseases (Feinstein, 2007) and is thought to be a combination of psychosocial factors consequential to the disease, such as uncertainty, accumulation of disability, loss of work and independence, and biological changes that result from the disease (Arnett, Barwick, & Beeney, 2008). There has been less research into anxiety disorders; however, prevalence of clinically significant anxiety has been reported as 25-51% (Janssens, van Doorn, de Boer, Kalkers, et al, 2003;Korostil & Feinstein, 2007;Moreau, Schmidt, Joyeux, & Bungener, 2009). Management of depression and anxiety in PwMS is important as it has been linked to increased quality of life (QoL) and adherence to disease-modifying treatments (Bruce, Hancock, Arnett, & Lynch, 2010).…”
mentioning
confidence: 99%